• Home
  • IAF Digital Library
  • Public Website
  • My papers
  • Home
  • event
  • IAC-16
  • B3
  • 3
  • session 3

    Title

    Utilization & Exploitation of Human Spaceflight Systems

    type

    oral

    Description

    This session addresses the utilization and exploitation of space stations and human spacecraft and provides the opportunity to discuss achievements, plans and outlooks. Topics for discussion include proposed or available payload facilities, experiments, research, manufacturing, and other on-orbit activity and its related planning, accommodation, and implementation. Additional items appropriate for discussion include scientific and industrial utilization applications and engineering research and technology demonstrations, as well as uses of space stations (ie. International Space Station and Tjangong) and other manned vehicles as test beds for exploration.

    Date

    2016-09-27

    Time

    14:45

    Room

    Guadalajara Hall Salon 2

    IPC members
    • Co-Chair: Mr. Kevin D. Foley, The Boeing Company, United States;

    • Co-Chair: Dr. Annamaria Piras, Thales Alenia Space Italia, Italy;

    • Rapporteur: Mr. Shannon Ryan, Defence Science and Technology Organisation (DSTO), Australia;

    papers

    Order

    Time

    Paper title

    Mode

    Presentation status

    Speaker

    Affiliation

    Country

    1

    International Research Results and Accomplishments from the International Space Station--A New Compilation

    20'

    confirmed

    Dr. Camille Alleyne

    NASA

    United States

    2

    ESA's Future Utilisation Programme for the ISS and complementary platforms

    20'

    confirmed

    Dr. Marc Heppener

    European Space Agency (ESA)

    The Netherlands

    3

    Russian ISS Research Program

    20'

    confirmed

    Dr. George Karabadzhak

    Central Research Institute for Machine Building (FGUP TSNIIMASH)

    Russian Federation

    4

    Canadian Space Agency Utilisation of the International Space Station in 2015

    20'

    confirmed

    Dr. Nicole Buckley

    Canadian Space Agency

    Canada

    5

    The first JAXA mice experiment in Kibo operations, its unique features and operational considerations

    20'

    confirmed

    Mr. Keiichiro Sakagami

    Japan Aerospace Exploration Agency (JAXA)

    Japan

    6

    Orphan drug development for Duchenne muscular dystrophy by protein crystallization in space

    20'

    confirmed

    Dr. Yoshihiro Urade

    Osaka Bioscience Institute

    Japan

    7

    Opportunities for Low-Earth Orbit Utilization, Current and Future

    20'

    confirmed

    Mr. Jeffrey Manber

    Nanoracks LLC

    United States

    8

    Deep Space Commonality and Standards Concepts

    20'

    confirmed

    Mr. Matthew Duggan

    The Boeing Company

    United States

    9

    Conceptual Design of a Human Spaceflight Platform as ISS successor

    20'

    confirmed

    Mr. Marius Schwinning

    University of Stuttgart

    Germany

    10

    Life in low-Earth orbit after the International Space Station

    20'

    confirmed

    Mr. Sam Scimemi

    National Aeronautics and Space Administration (NASA)

    United States